Here are five observations:
1. In 2014, the CTDR device market captured 66 percent of the global total disc replacement market.
2. The CTDR device market is expected to be worth $1.75 billion by 2021.
3. The growing number of chronic disease cases as well as the increasing aging population will boost the CTDR device market.
4. North America is anticipated to continue dominating the market, with the Asian market growing at a 23.8 percent CAGR and the Latin American market growing at an 18.5 percent CAGR through 2021.
5. Dublin, Ireland-based Medtronic; Raynham, Mass.-based Depuy Synthes; Audubon, Pa.-based Globus Medical; and San Diego-based NuVasive are leading players, among others.
More articles on devices:
10 things to know about Medtronic
DePuy Synthes and LifeNet Health collaborate to create ViviGen Formable Cellular Bone Matrix — 6 details
OrthoPediatrics caters to neglected pediatric market — 6 observations
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
